Theranostics of reduction of cardiotoxicity using targeted apoptosis activation technology
Ended Cooperative Agreement Awarded Last action
- Award ID
- R43CA214223
- Recipient
-
Sci-Engi-Medco Solutions, Inc. UEI QFW6NVACLNU3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $274,452
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Place of performance
- St Peters, MO 63303, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $274,452 |
Quick answers
Who received award R43CA214223?
R43CA214223 was awarded to Sci-Engi-Medco Solutions, Inc. by National Cancer Institute (National Institutes of Health) on September 6, 2017.
How much is award R43CA214223 worth?
$274,452 has been obligated on R43CA214223.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award